Development asset linked to Anhui Huaheng Biotechnology in public FDA and regional records.
pharma · Chronic Obstructive Pulmonary Disease · Tuberculosis
Anhui Huaheng Biotechnology
Anhui Hemay Pharmaceutical Co., Ltd
Anhui Huaheng Biotechnology drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Hefei, CN HQ
2005 Founded
32 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hefei, CN
- Founded
- 2005
- Employees
- 32
- Programs
- 2
- Drugs
- 6
- Patents
- 0
Anhui Huaheng Biotechnology pipeline
Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Anhui Huaheng Biotechnology drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Anhui Huaheng Biotechnology in public FDA and regional records.
-
Development asset linked to Anhui Huaheng Biotechnology in public FDA and regional records.
-
Various (V04) compound in Anhui Huaheng Biotechnology's portfolio.
-
US regulatory status: approved.
-
Development asset linked to Anhui Huaheng Biotechnology in public FDA and regional records.